US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 18.280
  • -0.430-2.30%
Close Nov 21 16:00 ET
  • 18.280
  • 0.0000.00%
Post 20:01 ET
2.27BMarket Cap-3931P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arrowhead Pharmaceuticals Q4 2024 Estimates Date

Currency：USDNov 26, 2024

Estimate YoY
Revenue
58.91M
+265.99%
EPS
-0.87
+14.59%
Analyst Rating
Buy

Nov 21, 2024

Arrowhead Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 15.493M--
Nov 26, 20242024/Q4-- / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--
May 9, 20242024/Q20.000 / 56.830M--
--2024/Q13.551M / 29.636M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 15.493M--
Nov 26, 20242024/Q4-- / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--
May 9, 20242024/Q20.000 / 56.830M--
--2024/Q13.551M / 29.636M--

Unlock Free Earnings Estimates

Arrowhead Pharmaceuticals Earnings Reports

  • Arrowhead Pharmaceuticals | 8-K: Arrowhead Pharmaceuticals Reports Fiscal 2024 Third Quarter Results

    Aug 9 04:53

  • Arrowhead Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Aug 9 04:50

  • Arrowhead Pharmaceuticals | 8-K: Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results

    May 10 05:10

  • Arrowhead Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    May 10 04:18

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Buy

    • Buy

      60.00%

    • Hold

      40.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data